ENG/中
老虎證券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Virtus LifeSci Biotech Products ETF
103.46
-0.0139
-0.01%
盤後:
103.45
-0.0097
-0.01%
19:30 EDT
成交量:
8,264
成交額:
85.86萬
市值:
1.14億
市盈率:
- -
高:
104.51
開:
104.48
低:
103.45
收:
103.47
52周最高:
110.05
52周最低:
68.05
股本:
110.00萬
流通股本:
110.00萬
量比:
0.98
換手率:
0.75%
股息:
- -
股息率:
- -
淨資產收益率:
--
總資產收益率:
--
市淨率:
--
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞
公告
概念
沒有相關數據
資金流向
資金流入:
資金流出:
實時
日
周
月
季度
年
新聞
118款生物藥專利懸崖將至,中國藥企業迎戰MNC最大專利懸崖
蓝鲸财经
·
09/10
復宏漢霖朱儁:未來所有製藥企業都是AI製藥企業,不存在不依賴AI的生物製藥企業
睿见Economy
·
09/05
特朗普:8月就業數據超預期,要求聯儲局降息
特朗普社媒动态
·
09/04
康寧傑瑞生物製藥回購56,000股 耗資492,430港元
财闻
·
09/04
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/BBP"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BBP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBP\",,,,,undefined,":{"symbol":"BBP","market":"US","secType":"STK","nameCN":"Virtus LifeSci Biotech Products ETF","latestPrice":103.4597,"timestamp":1789156800000,"preClose":103.4736,"halted":0,"volume":8264,"hourTrading":{"tag":"盘后","latestPrice":103.45,"preClose":103.4597,"latestTime":"19:30 EDT","volume":7,"amount":724.2785,"timestamp":1789169406685,"change":-0.0097,"changeRate":-0.000094,"amplitude":0},"delay":0,"changeRate":-0.00013433378175695717,"floatShares":1100004,"shares":1100004,"eps":0,"marketStatus":"休市中","change":-0.0139,"latestTime":"09-11 16:00:00 EDT","open":104.48,"high":104.51,"low":103.45,"amount":858590.9244799999,"amplitude":0.010244,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":103.4736,"sharesOutstanding":600004,"nav":103.503,"aum":113853473.24,"bidAskSpread":0.002245,"preHourTrading":{"tag":"盘前","latestPrice":103.4736,"preClose":103.4736,"latestTime":"07:00 EDT","volume":2,"amount":206.9472,"timestamp":1789124458151,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":103.45,"preClose":103.4597,"latestTime":"19:30 EDT","volume":7,"amount":724.2785,"timestamp":1789169406685,"change":-0.0097,"changeRate":-0.000094,"amplitude":0},"volumeRatio":0.9846065698607303,"impliedVol":0.2114,"impliedVolPercentile":0.2749},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBP\",,,,,undefined,":{"symbol":"BBP","floatShares":1100004,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.9846065698607303,"shares":1100004,"dividePrice":0,"high":104.51,"amplitude":0.010244,"preClose":103.4736,"low":103.45,"week52Low":68.046,"pbRate":"--","week52High":110.05,"institutionHeld":0,"latestPrice":103.4597,"eps":0,"divideRate":0,"volume":8264,"delay":0,"ttmEps":0,"open":104.48,"prevYearClose":79.9149,"prevWeekClose":108.3272,"prevMonthClose":106.46,"prevQuarterClose":96.2686,"fiveDayClose":108.8566,"twentyDayClose":101.0899,"sixtyDayClose":87.5667},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBP\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBP\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBP\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666563124","title":"118款生物藥專利懸崖將至,中國藥企業迎戰MNC最大專利懸崖","url":"https://stock-news.laohu8.com/highlight/detail?id=2666563124","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666563124?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 15:26","pubTimestamp":1789025185,"startTime":"0","endTime":"0","summary":"BCG合伙人杜菁博士指出,未来几年全球MNC将迎来史上最大专利悬崖,有118种生物制剂将会失去相应的专利保护,涉及2340亿美元市场。然而,目前这118款即将到期分子中,只有极少数在火热开发,大量缺口有待生物类似药填补。目前来说,创新药出海还没办法完成这个闭环,但生物类似药作为先头部队做出海试验,企业风险和获益会更高。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1789025064363150858","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["FXH","MEDI","JDOC","PPH","IYH","TRUH","159839","RSPH","APXH","PJP","BBH","FHLC","TMED","BBP","GSKH","IHE","PBPH","BME"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665936888","title":"復宏漢霖朱儁:未來所有製藥企業都是AI製藥企業,不存在不依賴AI的生物製藥企業","url":"https://stock-news.laohu8.com/highlight/detail?id=2665936888","media":"睿见Economy","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665936888?lang=zh_tw&edition=fundamental","pubTime":"2026-09-05 14:04","pubTimestamp":1788588240,"startTime":"0","endTime":"0","summary":"朱俊坦言,尽管近年来国家批准的创新药数量已领先全球,但临床疗效的提升依然艰难。他强调,如果AI不能进一步赋能,生物医药产业将继续处于原始状态。未来,所有的制药企业都必须是AI制药企业,不存在不依赖AI的生物制药企业。朱俊总认为,在全球变局下,只要企业能够用好AI、抓住精准人群并解决真实的临床痛点,即使十个机会中只能抓住一个,也足以支撑企业的长远发展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/hy/hyjz/2026-09-05/doc-iniquccs3668085.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["QTOC","HK0000320264.USD","BK1191","VTHR","BK1161","01477","MRNX","ARTY","AIPO","BBP","HK0000306701.USD","03069","BK1574","HK0000306685.HKD","02696","HK0000320223.HKD","IBBQ","CHAT","MRNY","HK0000165453.HKD","AGIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132454908","title":"特朗普:8月就業數據超預期,要求聯儲局降息","url":"https://stock-news.laohu8.com/highlight/detail?id=1132454908","media":"特朗普社媒动态","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132454908?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 21:41","pubTimestamp":1788529306,"startTime":"0","endTime":"0","summary":"","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FXR","DFUV",".DJI","LRCY",".SPX","PEVC","AVSD","UCC","IJK","VAW","CAOS","ANEW","KOMP","FXL","TSLP","BBP","CLIX","RJZ","CGDV",".IXIC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664337721","title":"康寧傑瑞生物製藥回購56,000股 耗資492,430港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2664337721","media":"财闻","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664337721?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 20:53","pubTimestamp":1788526380,"startTime":"0","endTime":"0","summary":"9月4日,康宁杰瑞生物制药于2026年9月4日在香港联交所回购56,000股普通股,每股回购价格最高HKD8.8、最低HKD8.75,付出价格总额HKD492,430。回购股份拟持作库存股份,拟注销数目为0。回购后,已发行股份数目由968,056,697股减至968,000,697股,库存股份数目由6,325,000股增至6,381,000股,已发行股份总数维持974,381,697股。此次回购依据2026年6月12日获通过的回购授权进行,该授权可回购股份总数为96,850,669股。回购后暂止期截至2026年10月4日。呈交者为执行董事徐霆。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2026-09-04/doc-iniqsrak4001786.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["CNAV","03069","BBP","EWH","MRNY","MRNX","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":10,"pageCount":1,"totalSize":39,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/BBP\",params:#limit:6,delay:false,,,undefined,":[]}}